Liaoning Cheng Da Co

Liaoning Cheng Da Co Gross Margin

The Gross Margin of Liaoning Cheng Da Co (600739.SS) as of Nov 4, 2026 is 13.05 %. In the previous year, Gross Margin was 13.11 % — a change of -0.51% (lower).

Gross Margin

13.05 %

YoY

-0.51%

Last updated:

Gross Margin of Liaoning Cheng Da Co is 2025 13.05 % . Gross Margin of Liaoning Cheng Da Co was 2024 13.11 % . It decreases by -0.51% lower compared to the previous year.

Liaoning Cheng Da Co's gross margin stands at 13.0%, broadly stable from 13.8% several years earlier.

The Liaoning Cheng Da Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
11.64 CNY
Jan 1, 2019
14.32 CNY
Jan 1, 2020
12.59 CNY
Jan 1, 2021
13.81 CNY
Jan 1, 2022
17.83 CNY
Jan 1, 2023
11.95 CNY
Jan 1, 2024
13.11 CNY
Jan 1, 2025
13.05 CNY
The Liaoning Cheng Da Co Gross Margin history
YEARGross MarginYoY
13.05 %-0.51%
13.11 %+9.73%
11.95 %-32.95%
17.83 %+29.10%
13.81 %+9.64%
12.59 %-12.04%
14.32 %+23.03%
11.64 %-18.66%
14.31 %-38.41%
23.23 %+72.06%
13.50 %-4.23%
14.09 %+10,412.26%
0.13 %-9.17%
0.15 %-10.07%
0.16 %-29.31%
0.23 %+19.57%
0.19 %+38.77%
0.14 %-1.53%
0.14 %+36.83%
0.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Liaoning Cheng Da Co Stock analysis

What does Liaoning Cheng Da Co do? Liaoning Cheng Da Co., Ltd. generates revenue through four business segments. The Commodity Trading segment sells pharmaceuticals, oil, coal, and steel to retail and wholesale customers. The Biopharmaceutical Manufacturing segment develops and markets human and animal vaccines. The Energy Development segment extracts and sells oil. The Financial Services segment manages long-term investments and funds. The company serves domestic and international markets with these products and services. The firm's pharmaceutical and commodity trading activities target healthcare providers and industrial clients. Vaccine production caters to medical and veterinary markets. Oil sales focus on energy sector buyers. Investment services attract institutional and private investors. All segments operate across China and global markets. Liaoning Cheng Da's revenue streams include pharmaceutical retail and wholesale, commodity trading, vaccine sales, oil production, and financial fund management. The company's diverse portfolio spans healthcare, energy, and finance sectors. Its operations serve both local and international clients through established distribution channels. Liaoning Cheng Da Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Liaoning Cheng Da Co stock

Gross Margin of Liaoning Cheng Da Co is 13.05 % in 2025.

Gross Margin of Liaoning Cheng Da Co changed from 13.11 % to 13.05 %, representing a -0.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Liaoning Cheng Da Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Liaoning Cheng Da Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Liaoning Cheng Da Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Liaoning Cheng Da Co